Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor

被引:81
|
作者
Hudson, Brian D. [1 ]
Hebert, Terence E. [3 ]
Kelly, Melanie E. M. [1 ,2 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 1X5, Canada
[2] Dalhousie Univ, Dept Ophthalmol, Halifax, NS B3H 1X5, Canada
[3] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
关键词
PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; BETA-ADRENERGIC RECEPTORS; HUMAN TRABECULAR MESHWORK; D-2; DOPAMINE-RECEPTORS; ENDOCANNABINOID SYSTEM; CONCURRENT STIMULATION; FUNCTIONAL SELECTIVITY; CAMP ACCUMULATION; INVERSE AGONISTS;
D O I
10.1124/mol.109.060251
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Seven-transmembrane G protein-coupled receptors (GPCRs) represent the single largest family of cell surface receptors. Signaling through these receptors is controlled by changes in the conformation of the receptor from inactive to active conformations, which in turn lead to the activation of multiple downstream signaling pathways. To facilitate greater diversity in signaling responses, many of these receptors are capable of adopting several distinct active conformations, in which each couples preferentially to its own set of downstream signaling partners. Because these unique signaling responses result from specific receptor active conformations, GPCR signaling may be directed toward these selective responses through either strength-of-signal effects resulting from partial agonism or through biased agonism and functional selectivity, resulting from the selective stabilization of one active conformation over the others. This review uses the CB 1 cannabinoid receptor as a specific example to highlight the contribution of two important aspects of GPCR function-orthosteric ligand binding and receptor heterodimerization-toward directed GPCR signaling.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] CB1 Cannabinoid Receptor Signaling and Biased Signaling
    Leo, Luciana M.
    Abood, Mary E.
    [J]. MOLECULES, 2021, 26 (17):
  • [2] Cannabinoid CB1 and CB2 Receptor Signaling and Bias
    Ibsen, Mikkel Soes
    Connor, Mark
    Glass, Michelle
    [J]. CANNABIS AND CANNABINOID RESEARCH, 2017, 2 (01) : 48 - 60
  • [3] Molecular basis for ligand modulation of the cannabinoid CB1 receptor
    Ramesh, Karthik
    Rosenbaum, Daniel M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (14) : 3487 - 3495
  • [4] Ligand based structural studies of the CB1 cannabinoid receptor
    Picone, RP
    Fournier, DJ
    Makriyannis, A
    [J]. JOURNAL OF PEPTIDE RESEARCH, 2002, 60 (06): : 348 - 356
  • [5] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    [J]. DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [6] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
  • [7] CB1 cannabinoid receptor antagonists
    Barth, F
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
  • [8] CB1 cannabinoid receptor ligands
    Thakur, GA
    Nikas, SP
    Makriyannis, A
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
  • [9] The Cannabinoid CB1 Receptor in Schizophrenia
    Borgan, Faith
    Kokkinou, Michelle
    Howes, Oliver
    [J]. BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
  • [10] Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor
    Jakowiecki, Jakub
    Filipek, Slawomir
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (12) : 2457 - 2466